BioCentury | Apr 8, 2021
Finance

Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

...and co-founder David Walt. Vizgen plans to launch MERSCOPE, its single-cell spatial genomics platform, this summer. Inscripta...
...investors including Polaris Partners, Droia Ventures, Arch Venture Partners and Quark Venture. BC Staff CD388 Icosavax Inc. Nucleix Ltd. Vizgen Inc. Inscripta Inc. Metagenomi Volastra...
BioCentury | Nov 3, 2020
Management Tracks

Baldry joins Freeline as chief commercial officer; plus moves at X4, Cullinan, Surrozen, QurAlis, NantKwest, Seres, Canbridge, SQZ, AM-Pharma, Tempest and more

...CMO. Whiting previously served as SVP of clinical development at Calithera Biosciences Inc. (NASDAQ:CALA).Digital genome engineering company Inscripta Inc. appointed...
BioCentury | Dec 11, 2019
Financial News

Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine

...Inscripta raises $125M series D Inscripta Inc. raised $125 million in a series D round led by...
...Capital Management and Oak HC/FT participated in the round, as did additional undisclosed existing investors. Inscripta...
...ear nose and throat disorders. Hongjiang Li, Staff Writer Suzhou Ribo Life Science Co. Ltd. Hummingbird Bioscience Pte. Ltd. Inscripta Inc. Aurinia...
BioCentury | Nov 20, 2019
Finance

With Foresite backing $90M round, GenapSys rolls out a smaller, cheaper sequencer

...has invested in multiple sequencing applications, with a portfolio that includes 10x Genomics Inc. (NASDAQ:TXG), Inscripta Inc....
BioCentury | May 1, 2019
Company News

Management tracks: Gilead, bluebird, Apollomics

...succeeds co-founder and CEO Harry Stylli, who will continue as executive chairman. Gene editing play Inscripta Inc....
...partner at Foster Pepper. Hongjiang Li, Staff Writer Adicet Bio Inc. Apollomics Inc. Applied Therapeutics Inc. bluebird bio Inc. Gilead Sciences Inc. Inscripta Inc. Swedish...
BioCentury | Dec 21, 2018
Financial News

Inscripta adds $30M to series C to speed use of its gene editing tools

...and NanoDimension, and all six participated in the series C expansion. The additional funds bring Inscripta's...
...declined to disclose whether the expansion is the round's final close (see "Genome Toolbox" ). Inscripta...
...Illumina Inc. (NASDAQ:ILMN) employees. The company has raised $114.5 million to date. Inscripta Inc., Boulder, Colo. Sandi Wong Inscripta Inc. CRISPR MAD7...
BioCentury | Dec 19, 2018
Financial News

Inscripta adds $30M to series C to speed use of its gene editing tools

...and NanoDimension, and all six participated in the series C expansion. The additional funds bring Inscripta's...
...declined to disclose whether the expansion is the round's final close (see "Genome Toolbox" ). Inscripta...
...increase the speed and efficiency of CRISPR-based gene editing. CEO Kevin Ness told BioCentury that Inscripta's...
BioCentury | Nov 6, 2018
Company News

Management tracks: Audentes, Veloxis

...BioCentury that Blackthorn has searches underway to fill out its executive team. Gene editing play Inscripta Inc....
BioCentury | Mar 2, 2018
Finance

Genome toolbox

...The syndicate behind Inscripta Inc.’s $55.5 million series C round includes investors well-versed in genome reading and...
...which closed on Feb. 28, joined by existing investors Venrock, Foresite, MLS Capital and NanoDimension. Inscripta...
...from a somewhat laborious, linear progression of insight and invention to exponential progression.” In December, Inscripta...
BioCentury | Feb 28, 2018
Financial News

Inscripta raises $55.5M series C

...Gene editing play Inscripta Inc. (Boulder, Colo.) raised $55.5 million in a series C round led by...
...plans to provide its CRISPR enzyme, MAD7, free of charge to researchers for R&D use. Inscripta...
...such as manufacturing, inclusion in therapeutics or resale (see BioCentury Extra, Dec. 13, 2017) . Virginia Li Inscripta Inc....
Items per page:
1 - 10 of 14
BioCentury | Apr 8, 2021
Finance

Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

...and co-founder David Walt. Vizgen plans to launch MERSCOPE, its single-cell spatial genomics platform, this summer. Inscripta...
...investors including Polaris Partners, Droia Ventures, Arch Venture Partners and Quark Venture. BC Staff CD388 Icosavax Inc. Nucleix Ltd. Vizgen Inc. Inscripta Inc. Metagenomi Volastra...
BioCentury | Nov 3, 2020
Management Tracks

Baldry joins Freeline as chief commercial officer; plus moves at X4, Cullinan, Surrozen, QurAlis, NantKwest, Seres, Canbridge, SQZ, AM-Pharma, Tempest and more

...CMO. Whiting previously served as SVP of clinical development at Calithera Biosciences Inc. (NASDAQ:CALA).Digital genome engineering company Inscripta Inc. appointed...
BioCentury | Dec 11, 2019
Financial News

Dec. 10 Financial Quick Takes: Inscripta, Aurinia, Akeso, Ribo, Hummingbird, ImmunOs, Peregrine

...Inscripta raises $125M series D Inscripta Inc. raised $125 million in a series D round led by...
...Capital Management and Oak HC/FT participated in the round, as did additional undisclosed existing investors. Inscripta...
...ear nose and throat disorders. Hongjiang Li, Staff Writer Suzhou Ribo Life Science Co. Ltd. Hummingbird Bioscience Pte. Ltd. Inscripta Inc. Aurinia...
BioCentury | Nov 20, 2019
Finance

With Foresite backing $90M round, GenapSys rolls out a smaller, cheaper sequencer

...has invested in multiple sequencing applications, with a portfolio that includes 10x Genomics Inc. (NASDAQ:TXG), Inscripta Inc....
BioCentury | May 1, 2019
Company News

Management tracks: Gilead, bluebird, Apollomics

...succeeds co-founder and CEO Harry Stylli, who will continue as executive chairman. Gene editing play Inscripta Inc....
...partner at Foster Pepper. Hongjiang Li, Staff Writer Adicet Bio Inc. Apollomics Inc. Applied Therapeutics Inc. bluebird bio Inc. Gilead Sciences Inc. Inscripta Inc. Swedish...
BioCentury | Dec 21, 2018
Financial News

Inscripta adds $30M to series C to speed use of its gene editing tools

...and NanoDimension, and all six participated in the series C expansion. The additional funds bring Inscripta's...
...declined to disclose whether the expansion is the round's final close (see "Genome Toolbox" ). Inscripta...
...Illumina Inc. (NASDAQ:ILMN) employees. The company has raised $114.5 million to date. Inscripta Inc., Boulder, Colo. Sandi Wong Inscripta Inc. CRISPR MAD7...
BioCentury | Dec 19, 2018
Financial News

Inscripta adds $30M to series C to speed use of its gene editing tools

...and NanoDimension, and all six participated in the series C expansion. The additional funds bring Inscripta's...
...declined to disclose whether the expansion is the round's final close (see "Genome Toolbox" ). Inscripta...
...increase the speed and efficiency of CRISPR-based gene editing. CEO Kevin Ness told BioCentury that Inscripta's...
BioCentury | Nov 6, 2018
Company News

Management tracks: Audentes, Veloxis

...BioCentury that Blackthorn has searches underway to fill out its executive team. Gene editing play Inscripta Inc....
BioCentury | Mar 2, 2018
Finance

Genome toolbox

...The syndicate behind Inscripta Inc.’s $55.5 million series C round includes investors well-versed in genome reading and...
...which closed on Feb. 28, joined by existing investors Venrock, Foresite, MLS Capital and NanoDimension. Inscripta...
...from a somewhat laborious, linear progression of insight and invention to exponential progression.” In December, Inscripta...
BioCentury | Feb 28, 2018
Financial News

Inscripta raises $55.5M series C

...Gene editing play Inscripta Inc. (Boulder, Colo.) raised $55.5 million in a series C round led by...
...plans to provide its CRISPR enzyme, MAD7, free of charge to researchers for R&D use. Inscripta...
...such as manufacturing, inclusion in therapeutics or resale (see BioCentury Extra, Dec. 13, 2017) . Virginia Li Inscripta Inc....
Items per page:
1 - 10 of 14